Trial Profile
Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary) ; Ferrous sulfate
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 17 Jan 2019 Planned End Date changed from 31 Dec 2018 to 1 Apr 2019.
- 17 Jan 2019 Planned primary completion date changed from 31 Oct 2018 to 1 Apr 2019.
- 28 Aug 2017 Status changed from not yet recruiting to recruiting.